Growth hormone as a new treatment modality for short children with chronic renal failure

Hormone Research in Paediatrics

Volumn 46, Issue 4-5, 1996, Pages 230-235

  Mehls, O ^a,b   Haffner, D ^a,b   Wuhl E ^a,b   Tonshoff B ^a   Schaefer, F ^a   Heinrich, U ^a   Bittner, K ^b   Ehrich, J H H ^b   Filler, G ^b   Gellermann, J ^b   Hampel, H ^b   Bachmann, H ^b   Ruder, H ^b   Bonzel, K E ^b   Scheller, B ^b   Dippell, J ^b   Zimmerhackl, L B ^b   Kreuder, J ^b   Rascher, W ^b   Muller Wiefel D E ^b   Misselwitz, J ^b   Ronnefarth B ^b   Querfeld, U ^b   Eichstadt H ^b   Greiner, C ^b   Keller, E ^b   Weber, H P ^b   Heise, H R ^b   Wiemann, D ^b   Beetz, R ^b   Sasse, D ^b   Soergel, M ^b   Pistor, K ^b   Zlotkowski, A ^b   Klare, B ^b   Eife, R ^b   Kuwertz Broking E ^b   Wigger, M ^b   Mix, M ^b   Eicher, O ^b   more..

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE   (Germany)

Author keywords

Chronic renal failure; Dialysis; Growth failure; Growth hormone; Renal transplantation

Indexed keywords

CORTICOSTEROID; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AVASCULAR NECROSIS; BODY HEIGHT; CHILD; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DIALYSIS; DRUG EFFECT; EPIPHYSIOLYSIS; GLUCOSE METABOLISM; GROWTH DISORDER; HORMONAL THERAPY; HUMAN; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; RECOMBINANT PROTEINS; RENAL DIALYSIS;

EID: 10344231953     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185028     Document Type: Article

References (54)

1. Schaefer F, Mehls O: Endocrine, metabolic and growth disorders: in Holliday MA, Barratt TM, Avner ED (eds): Paediatric Nephrology, Baltimore, Williams & Wilkins, 1987, pp 1241-1286.
2. Tdnshoff B, Schaefer F, Mehls O: Disturbances of growth hormone-insulin-like growth factor axis in uremia, Pediatr Nephrol 1990,4:654-662.
3. Koch VH, Lippe BM, Nelson PA, Boechat MI, Sherman BM: Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure, J Pediatr 1989:115:365-371.
4. Tönshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A: Growth stimulating effects of recombinant human growth hormone in children with end-stage renal disease, J Pediatr 1990:116:561-566.
5. Tönshoff B, Haffner D, Mehls O, Dietz M, Ruder H, Blum WF, Heinrich U, Stöver B, German Study Group for growth hormone treatment in children with renal allografts: Efficacy and safety of growth hormone treatment in short children with renal allografts: Three year experience, Kidney Int 1993:44:199-207.
6. Davidson M, Fisher M, Dabir-Vaziri N: Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia, Metabolism 1976:25:455-464.
7. Haffner D, Schaefer F, Girard J, Ritz E, Mehls O: Metabolic clearance of recombinant human growth hormone in health and chronic renal failure, J Clin Invest 1994:93:1163-1171.
8. Schaefer F, Baumann G, Haffner D: Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: Regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma, J Clin Endocrinol Melab 1996: 81:22-31.
9. Schaefer F, Hamill G, Stanhope R, Prcece MA, Schärer K: Pulsatile growth hormone secretion in peripubertal patients with chronic renal failure, J Pediatr 1991;119:568-577.
10. Tönshot TB, Veldhuis JD, Heinrich U, Mchls O: Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with chronic renal failure, Pediatr Res 1995;37:86-93.
11. Postel-Vinay MC, Tar A, Crosnier H, Broyer M, Rappaport R, Tönshoff B, Mehls O: Plasma growth hormone binding protein is low in uraemic children, Pediatr Nephrol 1991:5: 545-547.
12. Tönshoff B, Edén S, Weiser E, Carlsson B, Robinson ICAF, Blum WF, Mehls O: Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia, Kidney Int 1994:45:1085-1092.
13. Tönshoff B, Cronin MJ, Reichert M, Wingen A, Haffner D, Blum WF, Mehls O: Reduced concentration of scrum growth hormone-binding protein (GHBP) in children with chronic renal insufficiency (CRI), 77th Annu Meet En-docr Soc, Washington, 1995, p 503.
14. Baumann G, Shaw MA, Ambum K: Regulation of plasma growth hormone-binding proteins in health and disease, Metabolism 1989: 38:683-689.
15. Powell D, Rosenfeld R, Sperry J, Baker B, Hintz R: Serum concentrations of insulin-like growth factor (IGFp), 1GF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure, Am J Kidney Dis 1987: 10:287-292.
16. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O: Excess of IGF-binding proteins in chronic renal failure: Evidence for relative GH resistance and inhibition of somatomedin activity: in Drop SLS, Hintz RL (eds): Insulin-Like Growth Factor Proteins, Amsterdam, Ex-cerpta Medica, 1989, pp 93-101.
17. Phillips LS, Pennisi AJ, Belosky DC, Uiltcnbo-gaart C, Ettcnger RB, Malekzadeh MH, Fine RN: Somatomedin activity and inorganic sulfate in children undergoing hemodialysis, J Clin Endocrinol Metab 1978:46:165-168.
18. Drop SLS, Brinkman A, Kortleve DJ, Groffcn CAH, Schuller A, Zwarthol TEC: The evolution of the insulin-like growth factor binding protein family; in Spencer EM (cd): Modern Concepts of Insulin-Like Growth Factors, New York, Elsevier, 1991, pp 311-328.
19. Tönshoff B, Blum WF, Wingen AM, Mchls O: Scrum insulin-likc growth factors (IGFs) and IGF binding proteins 1, 2 and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate, J Endocrinol Mctab 1995:80:2684-2691.
20. Tönshoff B, Powell DR, Zhao D, Domeñe HM, Blum WF, Moore LC, Kaskcl FJ: Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein (IGFBP)-I and -2 gene expression in experimental uremia, J Am Soc Nephrol 1995;6:1032.
21. Blum WF, Ranke MB, Kietzmann K, Tönshol TB, Mchls O: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia, Pediatr Nephrol 1991:5:539-544.
22. Blum WF: Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: Evidence for reduced secretion of IGFs, Acta PacdiatrScand Suppl 1991:379:24-31.
23. Casanucva FF, Burguera B, Tome M: Depending on the time of administration, dexametha-sonc potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man, Neuroendocrinology 1990:47: 46-49.
24. Veldhuis JD, Lizarraldc G, Iranmancsh A: Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men, J Clin Endocrinol Metab 1992:74:96-102.
25. Wehrenberg WB, Janowski BA, Piering AW, Culler F, Jones KL: Glucocorticoids: Potent inhibitors and stimulators of growth hormone secretion, Endocrinology 1990; 126:3200-3203.
26. Schaefer F, Veldhuis JD, Stanhope R, Jones J, Schärer K, Cooperative Study Group on Pubertal Development in Chronic Renal Failure: Alterations in growth hormone secretion and clearance in pcripubertal boys with chronic renal failure and after renal transplantation, J Clin Endocrinol Mctab 1994:78:1298-1306.
27. Gabriclsson BG, Carmignac DF, Flavell DM, Robinson ICAF: Steroid regulation of growth hormone (GH) receptor and GH binding protein messenger ribonucleic acids in the rat, Endocrinology 1995:133:2445-2452.
28. Tönshoff B, Mehls O: Use of rhGH posttransplantation in children: in Tejani AH, Fine RN (eds): Pediatric Renal Transplantation, New York, Wiley-Liss, 1994, pp 441-459.
29. Luo J, Murphy LJ: Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-1) messenger ribonucleic acid (mRNA) in hypophyseclomized rats and reduces IGF-t mRNA abundance in the intact rat, Endocrinology 1989:125:165-171.
30. Elders MJ, Wingfield BS, McNatt ML, Clarke JS, Hughes ER: Glucocorticoid therapy in children, Effect on somatomedin secretion, Am J Dis Child 1975:129:1393-1396.
31. Unterman TG, Phillips LS: Glucocorticoid effects on somatomcdins and somatomedin inhibitors, J Clin Endocrinol Metab 1985:61: 618-626.
32. Bang P, Dcgerblad M, Thoren M, Schwander J, Blum W, Hall K: Insulin-like growth factor (IGF) 1 and 11 and IGF binding protein (IGFBP) 1.2 and 3 in serum from patients with Cushing's syndrome, Acta Endocrinol 1993; 128:397-404.
33. Silbermann M, Maor G: Mechanimsms of glucocorticoid-induced growth retardation: Impairment of cartilage mineralization, Acta Anal 1978:101:140-149.
34. Jux C, Leiber K, Hügel U, et al: Dexamethasone inhibits GH stimulated and IGF-1 rne-diatcc proliferation by reduction of paracrine IGF-1 secretion and somatotropic receptor downregulalion in cultured growth plate chondrocytes (abstract), 10th Int Congr Endocrinol, San Francisco, 1996, in press.
35. Fine RN, Kohaut EC, Brown D, Perlman AJ: Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study, J Pediatr 1994:124:374-382.
36. Mehls O, Broyer M, on behalf of the European/Australian Study Group: Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis, Acta Pacdiatr Suppl 1994;399:81-87.
37. HafTner D, Wühl E, Tönshoff B, Mehls O: Growth hormone (GH) treament in short children with chronic renal failure (CRF): A 5 year follow-up (abstract), Pediatr Nephrol I994;8: C40.
38. Fine RN, Kohaut E, Brown D, Kuntze J, Attie KM: Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone, Kidney Int 1996;49:781-785.
39. Tonshoff B, Tönshof TC, Mchls O, Pinkowski J, Blum WF, Heinrich U, Stövcr B, Gretz N: Growth hormone treatment in children with prctcrminal chronic renal failure: No adverse effect on glomerular filtration rate, Eur J Pediatr 1992;151:601-607.
40. Wühl E, HafTner D, Nissel R, Schaefer F, Mehls O, and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure: Short dialyzcd children respond less to growth hormone than patients prior to dialysis, Pediatr Nephrol 1996:10:294-298.
41. Wühl E, Haffiter D, Tönshoff B, Mehls O, and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure: Predictors of growth response to rhGH in short children before and after renal transplantation, Kidney Int 1993;44(suppl):76-82.
42. Rees L, Rigden SPA, Ward G, Preece MA: Treatment of short stature in renal disease with recombinant human growth hormone, Arch Dis Child 1990:65:856-860.
43. Johannson G, Janssens F, Proesmans W, Van-derschueren-Lodeweyckx M, Holmbcrg C, Si-pilac I, Broycr M, Rappaport R, Albcrtsson-Wikland K, Berg U, Jodal U, Rilzcn M, Rees L, Ridgen S, Preece M, Sietniks A: Treatment with gcnotropin in short children with chronic renal failure, either before active replacement therapy or with functioning renal transplants: An interim report on five European studies, Acta Paediatr Scand Suppl 1990:370:36-42.
44. Bartosh S, Kaiser B, Rezvani I, Polinsky M, Schulman S, Palmer J, Baluarte HJ: Effects of growth hormone administration in pediatric allograft recipients, Pediatr Nephrol 1992:6:68-73.
45. Van Es A: Growth hormone treatment in short children with chronic renal failure and after renal transplantation: Combined data from European clinical trials, Acta Paediatr Scand Suppl 1991:379:42-48.
46. Fine RN, Yadin O, Moulten L, Nelson PA, Boechat MI, Lippe BM: Extended recombinant human growth hormone treatment after renal transplantation in children, J Am Soc Nephrol 1992;2(suppl):S274-S283.
47. Broyer M, on behalf of the study group: A mul-ticcnter, open, randomized, controlled study evaluating the effect of growth hormone therapy in short children after renal transplantation (abstract), Pediatr Nephrol 1995;9:C49.
48. Hokken-Koelega ACS, Stijnen T, De Ridder MAJ, deMuinckKeizer-Schrama AMPF, Wolff F.D, De Jong MCJW, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SLS: Growth hormone treatment in growth-retarded adolescents after renal transplantation, Lancet 1994:343:1313-1317.
49. Tonshoff B, Dietz M, Haffner D, Tonshol TC, Stover B, Mehls O: Effects of two years growth hormone treatment in short children with renal disease, Acta Paediatr Scand Suppl 1991:379: 33-41.
50. Haffner D, Zacharewicz S, Mehls O, Heinrich U, Ritz E: The acute effect of growth hormone on GFR is obliterated in chronic renal failure, Clin Nephrol 1989:32:266-269.
51. Ingulli E, Tejani AH: Steroid withdrawal after renal transplantation: in Tejani AH, Fine RN (eds): Pediatric Renal Transplantation, New York, Wilcy-Liss, 1994, pp 221-238.
52. Malozowski S, Tanner LA, Wysowski D, Fleming GA: Growth hormone, insulin-like growth factor 1, and benign intracranial hypertension, N Engl J Med 1993:329:665-666.
53. Watkins SL: Is severe renal osteodystrophy a contraindication for rhGH treatment? Pediatr Nephrol, in press.
54. Boechat ML, Watkins SL: Avascular necrosis in children with chronic renal disease (abstract), Soc Pediatr Radiol, 1995, p 55.